Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Body Radiation Therapy for cT1c - cT3a Prostate Cancer With a Low Risk of Nodal Metastases (≤ 20%, Roach Index): a Novalis Circle Phase II Prospective Randomized Trial

NCT01764646 is registered in ClinicalTrials.gov with Thomas Zilli as lead sponsor.

NCT NCT01764646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01764646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Body Radiation Therapy for cT1c - cT3a Prostate Cancer With a Low Risk of Nodal Metastases (≤ 20%, Roach Index): a Novalis Circle Phase II Prospective Randomized Trial
Lead sponsor
Thomas Zilli
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2012
Completion date
September 30, 2025
Enrollment
170 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

local disease, malignant neoplasm of prostate